Merck & Co Inc
NYSE: MRK
$95.44
+$0.79 (+0.8%)
Real Time Data Delayed 15 Min.
MRK Articles
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
Merck reported better-than-expected second-quarter results before the markets opened on Friday, but shares retreated afterward.
Published:
Last Updated:
The July 13 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
24/7 Wall St. has put together a preview of Boeing, Exxon, Verizon and other Dow industrials scheduled to report their quarterly results this week.
Published:
Last Updated:
Four pharmaceutical industry leaders are poised to report second-quarter results next week, and one key analyst sees the relatively good print from Johnson & Johnson as a good signal for the...
Published:
Last Updated:
The June 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
Intel, Walgreens, Johnson & Johnson, and Merck led the Dow higher Thursday.
Published:
Last Updated:
Merck shares retreated to start off the week despite the announcement of good news from the FDA.
Published:
Last Updated:
The June 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
The fear of a massive global trade war is one that has just not been part of the investing lexicon in years. So what are confused investors to do now?
Published:
Last Updated:
Intel, P&G, Travelers, and Merck were Monday's worst performing Dow stocks.
Published:
Last Updated:
General Electric, JPMorgan, Merck, and Coca-Cola weighed on the Dow Thursday.
Published:
Last Updated:
Merck & Co., Inc. (NYSE: MRK) shares took a small step back on Thursday after the company announced a key approval from the U.S. Food and Drug Administration. The agency has now approved Keytruda...
Published:
Last Updated:
Keep in mind that short sellers betting against big pharma are taking on an added risk. They have to pay out the ongoing high dividends on top of the cost of borrowing the shares.
Published:
Last Updated:
DowDuPont and GE were Tuesday's leading gainers among the Dow 30 stocks while Walmart and Merck, Monday's big gainers, were Tuesday's leading losers in a day of virtually no change to the index.
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.